Suppr超能文献

相似文献

2
Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
Semin Diagn Pathol. 2021 Jan;38(1):50-61. doi: 10.1053/j.semdp.2020.09.010. Epub 2020 Sep 25.
4
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Clin Cancer Res. 2015 Feb 1;21(3):632-41. doi: 10.1158/1078-0432.CCR-13-3310. Epub 2014 Jul 23.
5
The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2061-7. doi: 10.1158/1055-9965.EPI-09-0209. Epub 2009 Jun 30.
6
NOTCH1 and PIK3CA mutation are related to HPV-associated vulvar squamous cell carcinoma.
Pathol Res Pract. 2023 Nov;251:154877. doi: 10.1016/j.prp.2023.154877. Epub 2023 Oct 7.
9
The Genomic Landscape of Vulvar Squamous Cell Carcinoma.
Int J Gynecol Pathol. 2023 Sep 1;42(5):515-522. doi: 10.1097/PGP.0000000000000950. Epub 2023 May 3.
10
Role of TP53 mutations in vulvar carcinomas.
Int J Gynecol Pathol. 2011 Sep;30(5):497-504. doi: 10.1097/PGP.0b013e3182184c7a.

引用本文的文献

1
The Varying Faces of Vulvar Neoplasia.
Indian Dermatol Online J. 2025 Sep 1;16(5):773-777. doi: 10.4103/idoj.idoj_911_24. Epub 2025 Aug 29.
2
Vaginal Adenocarcinoma: A Review of a Rare Gynecologic Cancer.
Cancers (Basel). 2025 Jun 25;17(13):2130. doi: 10.3390/cancers17132130.
3
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature.
Clin Cosmet Investig Dermatol. 2025 Mar 18;18:617-626. doi: 10.2147/CCID.S512373. eCollection 2025.
4
Precision therapeutic targets for HPV-positive cancers: an overview and new insights.
Infect Agent Cancer. 2025 Mar 11;20(1):17. doi: 10.1186/s13027-025-00641-7.
5
Pathological variants in HPV-independent vulvar tumours.
Sci Rep. 2025 Jan 9;15(1):1486. doi: 10.1038/s41598-024-84688-3.
6
Molecular Subtypes of Vulvar Squamous Cell Carcinoma: The Significance of HPV-Independent/p53 Wild Type.
Cancers (Basel). 2024 Dec 18;16(24):4216. doi: 10.3390/cancers16244216.
7
A state-of-the-art systematic review of cancer in hidradenitis suppurativa.
Ann Med. 2024 Dec;56(1):2382372. doi: 10.1080/07853890.2024.2382372. Epub 2024 Jul 24.
9
Understanding the HPV associated cancers: A comprehensive review.
Mol Biol Rep. 2024 Jun 14;51(1):743. doi: 10.1007/s11033-024-09680-6.
10
Genomic profiles of Japanese patients with vulvar squamous cell carcinoma.
Sci Rep. 2024 Jun 6;14(1):13058. doi: 10.1038/s41598-024-63913-z.

本文引用的文献

1
Molecular Landscape of Vulvar Squamous Cell Carcinoma.
Int J Mol Sci. 2021 Jun 30;22(13):7069. doi: 10.3390/ijms22137069.
3
Targeted Molecular Sequencing of Recurrent and Multifocal Non-HPV-associated Squamous Cell Carcinoma of the Vulva.
Int J Gynecol Pathol. 2021 Jul 1;40(4):391-399. doi: 10.1097/PGP.0000000000000742.
4
Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Gynecol Oncol. 2020 Dec;159(3):649-656. doi: 10.1016/j.ygyno.2020.09.024. Epub 2020 Sep 21.
6
Tumor budding in cervical cancer as a prognostic factor and its possible role as an additional intermediate-risk factor.
Gynecol Oncol. 2020 Oct;159(1):157-163. doi: 10.1016/j.ygyno.2020.07.030. Epub 2020 Jul 31.
8
Cancer statistics, 2020.
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
10
Tumor Budding is a Valuable Diagnostic Parameter in Prediction of Disease Progression of Endometrial Endometrioid Carcinoma.
Pathol Oncol Res. 2019 Apr;25(2):723-730. doi: 10.1007/s12253-018-0554-x. Epub 2019 Jan 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验